Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 75
Filter
1.
AJNR Am J Neuroradiol ; 41(2): 238-245, 2020 02.
Article in English | MEDLINE | ID: mdl-32029467

ABSTRACT

BACKGROUND AND PURPOSE: Spiral MR imaging has several advantages compared with Cartesian MR imaging that can be leveraged for added clinical value. A multicenter multireader study was designed to compare spiral with standard-of-care Cartesian postcontrast structural brain MR imaging on the basis of relative performance in 10 metrics of image quality, artifact prevalence, and diagnostic benefit. MATERIALS AND METHODS: Seven clinical sites acquired 88 total subjects. For each subject, sites acquired 2 postcontrast MR imaging scans: a spiral 2D T1 spin-echo, and 1 of 4 routine Cartesian 2D T1 spin-echo/TSE scans (fully sampled spin-echo at 3T, 1.5T, partial Fourier, TSE). The spiral acquisition matched the Cartesian scan for scan time, geometry, and contrast. Nine neuroradiologists independently reviewed each subject, with the matching pair of spiral and Cartesian scans compared side-by-side, and scored on 10 image-quality metrics (5-point Likert scale) focused on intracranial assessment. The Wilcoxon signed rank test evaluated relative performance of spiral versus Cartesian, while the Kruskal-Wallis test assessed interprotocol differences. RESULTS: Spiral was superior to Cartesian in 7 of 10 metrics (flow artifact mitigation, SNR, GM/WM contrast, image sharpness, lesion conspicuity, preference for diagnosing abnormal enhancement, and overall intracranial image quality), comparable in 1 of 10 metrics (motion artifacts), and inferior in 2 of 10 metrics (susceptibility artifacts, overall extracranial image quality) related to magnetic susceptibility (P < .05). Interprotocol comparison confirmed relatively higher SNR and GM/WM contrast for partial Fourier and TSE protocol groups, respectively (P < .05). CONCLUSIONS: Spiral 2D T1 spin-echo for routine structural brain MR imaging is feasible in the clinic with conventional scanners and was preferred by neuroradiologists for overall postcontrast intracranial evaluation.


Subject(s)
Brain/diagnostic imaging , Magnetic Resonance Imaging/methods , Neuroimaging/methods , Adult , Aged , Artifacts , Female , Humans , Image Enhancement/methods , Male , Middle Aged
2.
AJNR Am J Neuroradiol ; 39(6): 1008-1016, 2018 06.
Article in English | MEDLINE | ID: mdl-29794239

ABSTRACT

BACKGROUND AND PURPOSE: Standard assessment criteria for brain tumors that only include anatomic imaging continue to be insufficient. While numerous studies have demonstrated the value of DSC-MR imaging perfusion metrics for this purpose, they have not been incorporated due to a lack of confidence in the consistency of DSC-MR imaging metrics across sites and platforms. This study addresses this limitation with a comparison of multisite/multiplatform analyses of shared DSC-MR imaging datasets of patients with brain tumors. MATERIALS AND METHODS: DSC-MR imaging data were collected after a preload and during a bolus injection of gadolinium contrast agent using a gradient recalled-echo-EPI sequence (TE/TR = 30/1200 ms; flip angle = 72°). Forty-nine low-grade (n = 13) and high-grade (n = 36) glioma datasets were uploaded to The Cancer Imaging Archive. Datasets included a predetermined arterial input function, enhancing tumor ROIs, and ROIs necessary to create normalized relative CBV and CBF maps. Seven sites computed 20 different perfusion metrics. Pair-wise agreement among sites was assessed with the Lin concordance correlation coefficient. Distinction of low- from high-grade tumors was evaluated with the Wilcoxon rank sum test followed by receiver operating characteristic analysis to identify the optimal thresholds based on sensitivity and specificity. RESULTS: For normalized relative CBV and normalized CBF, 93% and 94% of entries showed good or excellent cross-site agreement (0.8 ≤ Lin concordance correlation coefficient ≤ 1.0). All metrics could distinguish low- from high-grade tumors. Optimum thresholds were determined for pooled data (normalized relative CBV = 1.4, sensitivity/specificity = 90%:77%; normalized CBF = 1.58, sensitivity/specificity = 86%:77%). CONCLUSIONS: By means of DSC-MR imaging data obtained after a preload of contrast agent, substantial consistency resulted across sites for brain tumor perfusion metrics with a common threshold discoverable for distinguishing low- from high-grade tumors.


Subject(s)
Brain Neoplasms/diagnostic imaging , Datasets as Topic/standards , Glioma/diagnostic imaging , Image Interpretation, Computer-Assisted/standards , Magnetic Resonance Imaging/standards , Adult , Aged , Algorithms , Brain Neoplasms/pathology , Female , Glioma/pathology , Humans , Image Interpretation, Computer-Assisted/methods , Male , Middle Aged , National Cancer Institute (U.S.) , United States
3.
NMR Biomed ; 30(3)2017 Mar.
Article in English | MEDLINE | ID: mdl-26773848

ABSTRACT

Imaging biomarkers for the predictive assessment of treatment response in patients with cancer earlier than standard tumor volumetric metrics would provide new opportunities to individualize therapy. Diffusion-weighted MRI (DW-MRI), highly sensitive to microenvironmental alterations at the cellular level, has been evaluated extensively as a technique for the generation of quantitative and early imaging biomarkers of therapeutic response and clinical outcome. First demonstrated in a rodent tumor model, subsequent studies have shown that DW-MRI can be applied to many different solid tumors for the detection of changes in cellularity as measured indirectly by an increase in the apparent diffusion coefficient (ADC) of water molecules within the lesion. The introduction of quantitative DW-MRI into the treatment management of patients with cancer may aid physicians to individualize therapy, thereby minimizing unnecessary systemic toxicity associated with ineffective therapies, saving valuable time, reducing patient care costs and ultimately improving clinical outcome. This review covers the theoretical basis behind the application of DW-MRI to monitor therapeutic response in cancer, the analytical techniques used and the results obtained from various clinical studies that have demonstrated the efficacy of DW-MRI for the prediction of cancer treatment response. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Drug Monitoring/methods , Early Detection of Cancer/methods , Image Enhancement/methods , Neoplasms/diagnostic imaging , Neoplasms/therapy , Animals , Evidence-Based Medicine , Humans , Image Interpretation, Computer-Assisted/methods , Neoplasms/pathology , Reproducibility of Results , Sensitivity and Specificity , Treatment Outcome
4.
Eur Radiol ; 22(7): 1451-64, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22562143

ABSTRACT

Many therapeutic approaches to cancer affect the tumour vasculature, either indirectly or as a direct target. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has become an important means of investigating this action, both pre-clinically and in early stage clinical trials. For such trials, it is essential that the measurement process (i.e. image acquisition and analysis) can be performed effectively and with consistency among contributing centres. As the technique continues to develop in order to provide potential improvements in sensitivity and physiological relevance, there is considerable scope for between-centre variation in techniques. A workshop was convened by the Imaging Committee of the Experimental Cancer Medicine Centres (ECMC) to review the current status of DCE-MRI and to provide recommendations on how the technique can best be used for early stage trials. This review and the consequent recommendations are summarised here. Key Points • Tumour vascular function is key to tumour development and treatment • Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assess tumour vascular function • Thus DCE-MRI with pharmacokinetic models can assess novel treatments • Many recent developments are advancing the accuracy of and information from DCE-MRI • Establishing common methodology across multiple centres is challenging and requires accepted guidelines.


Subject(s)
Clinical Trials as Topic/standards , Contrast Media/standards , Magnetic Resonance Imaging/standards , Neoplasms/pathology , Neovascularization, Pathologic/pathology , Practice Guidelines as Topic , Europe , Humans , Neoplasms/blood supply , Reference Standards
5.
Neurology ; 78(20): 1596-600, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22517106

ABSTRACT

OBJECTIVES: To determine if there are in vivo differences in γ-aminobutyric acid (GABA) in the motor cortex and subcortical white matter of patients with amyotrophic lateral sclerosis (ALS) compared with healthy controls using proton magnetic resonance spectroscopy (1H-MRS). METHODS: In this cross-sectional study, 10 patients with ALS and 9 age- and sex-matched healthy controls (HCs) underwent 3T edited 1H-MRS to quantify GABA centered on the motor cortex and the subcortical white matter. RESULTS: Compared with healthy controls, patients with ALS had significantly lower levels of GABA in the left motor cortex (1.42 ± 0.27 arbitrary institutional units vs. 1.70 ± 0.24 arbitrary institutional units, p = 0.038). There was no significant difference in GABA levels between groups in the subcortical white matter (p > 0.05). CONCLUSION: Decreased levels of GABA are present in the motor cortex of patients with ALS compared to HCs. Findings are consistent with prior reports of alterations in GABA receptors in the motor cortex as well as increased cortical excitability in the context of ALS. Larger, longitudinal studies are needed to confirm these findings and to further our understanding of the role of GABA in the pathogenesis of ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/pathology , Motor Cortex/metabolism , gamma-Aminobutyric Acid/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/diagnostic imaging , Amyotrophic Lateral Sclerosis/metabolism , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Cross-Sectional Studies , Female , Humans , Magnetic Resonance Spectroscopy , Male , Middle Aged , Motor Cortex/diagnostic imaging , Protons , Radionuclide Imaging , Young Adult
6.
AJNR Am J Neuroradiol ; 31(4): 736-40, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20007723

ABSTRACT

BACKGROUND AND PURPOSE: Does the K-means algorithm do a better job of differentiating benign and malignant neck pathologies compared to only mean ADC? The objective of our study was to analyze the differences between ADC partitions to evaluate whether the K-means technique can be of additional benefit to whole-lesion mean ADC alone in distinguishing benign and malignant neck pathologies. MATERIAL AND METHODS: MR imaging studies of 10 benign and 10 malignant proved neck pathologies were postprocessed on a PC by using in-house software developed in Matlab. Two neuroradiologists manually contoured the lesions, with the ADC values within each lesion clustered into 2 (low, ADC-ADC(L); high, ADC-ADC(H)) and 3 partitions (ADC(L); intermediate, ADC-ADC(I); ADC(H)) by using the K-means clustering algorithm. An unpaired 2-tailed Student t test was performed for all metrics to determine statistical differences in the means of the benign and malignant pathologies. RESULTS: A statistically significant difference between the mean ADC(L) clusters in benign and malignant pathologies was seen in the 3-cluster models of both readers (P = .03 and .022, respectively) and the 2-cluster model of reader 2 (P = .04), with the other metrics (ADC(H), ADC(I); whole-lesion mean ADC) not revealing any significant differences. ROC curves demonstrated the quantitative differences in mean ADC(H) and ADC(L) in both the 2- and 3-cluster models to be predictive of malignancy (2 clusters: P = .008, area under curve = 0.850; 3 clusters: P = .01, area under curve = 0.825). CONCLUSIONS: The K-means clustering algorithm that generates partitions of large datasets may provide a better characterization of neck pathologies and may be of additional benefit in distinguishing benign and malignant neck pathologies compared with whole-lesion mean ADC alone.


Subject(s)
Algorithms , Diffusion Magnetic Resonance Imaging/methods , Image Processing, Computer-Assisted/methods , Otorhinolaryngologic Diseases/diagnosis , Otorhinolaryngologic Neoplasms/diagnosis , Adult , Diagnosis, Differential , Female , Humans , Male , Middle Aged , ROC Curve , Sensitivity and Specificity , Software , Young Adult
7.
J Magn Reson Imaging ; 29(2): 291-7, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19161192

ABSTRACT

PURPOSE: To assess if interval changes in metabolic status in normal cerebral tissue after radiation therapy (RT) can be detected by 2D CSI (chemical shift imaging) proton spectroscopy. MATERIALS AND METHODS: Eleven patients with primary brain tumors undergoing cranial radiation therapy (RT) were included. 2D-CSI MRS was performed before, during, and after the course of RT with the following parameters: TE/TR 144/1500 ms, field of view (FOV) 24, thickness 10 mm, matrix 16 x 16. The metabolic ratios choline/creatine (Cho/Cr), N-acetylaspartate (NAA)/Cr, and NAA/Cho in normal brain tissue were calculated. RESULTS: NAA/Cr and Cho/Cr were significantly decreased at week 3 during RT and at 1 month and 6 months after RT compared to values prior to RT (P < 0.01). The NAA/Cr ratio decreased by -0.19 +/- 0.05 (mean +/- standard error [SE]) at week 3 of RT, -0.14 +/- 0.06 at the last week of RT, -0.14 +/- 0.05 at 1 month after RT, and -0.30 +/- 0.08 at 6 months after RT compared to the pre-RT value of 1.43 +/- 0.04. The Cho/Cr ratio decreased by -0.27 +/- 0.05 at week 3 of RT, -0.11 +/- 0.05 at the last week of RT, -0.26 +/- 0.05 at 1 month after RT and -0.25 +/- 0.07 at 6 months after RT from the pre-RT value of 1.29 +/- 0.03. Changes in Cho/Cr were correlated with the interaction of the radiation dose and dose-volume at week 3 of RT, during the last week of RT (P < 0.005), and at 1 month after RT (P = 0.017). CONCLUSION: The results of this study suggest that MRS can detect early metabolic changes in normal irradiated brain tissue.


Subject(s)
Brain Neoplasms/radiotherapy , Brain/radiation effects , Magnetic Resonance Spectroscopy/methods , Radiation Injuries/metabolism , Adult , Aged , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Brain/metabolism , Brain Neoplasms/metabolism , Choline/metabolism , Creatine/metabolism , Female , Humans , Male , Middle Aged , Prospective Studies
8.
Acta Radiol ; 48(2): 213-22, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17354144

ABSTRACT

PURPOSE: To investigate whether apparent diffusion coefficient (ADC), fractional anisotropy (FA), and eigenvalues in neuropsychiatric systemic lupus erythematosus (NPSLE) patients differ from those of healthy controls. MATERIAL AND METHODS: Eight NPSLE patients (aged 23-55 years, mean 42.9 years) and 20 healthy age-matched controls (aged 22-59 years, mean 44.4 years) underwent conventional brain magnetic resonance (MR) and diffusion tensor imaging (DTI). The ADC, FA, principal eigenvalue (lambda parallel), and the corresponding average perpendicular eigenvalue (lambda perpendicular) (=(lambda2+lambda3)/2) were measured in selected regions of normal appearing gray and white matter brain parenchyma. For statistical evaluation of differences between the two groups, a Student's t-test was used. The P value for statistical significance was set to P=0.0025 after Bonferroni correction for multiple measurements. RESULTS: Significantly increased ADC values were demonstrated in normal-appearing areas in the insular cortex (P<0.001), thalamus (P<0.001), and the parietal and frontal white matter (P<0.001 and P<0.001, respectively) in NPSLE patients. Significantly decreased FA values were demonstrated in normal-appearing thalamus (P<0.001), corpus callosum (P=0.002), and in the parietal and frontal white matter (P<0.001 and P<0.001, respectively) in NPSLE patients compared to healthy controls. The lambda perpendicular was significantly higher in several of these regions in NPSLE patients compared to healthy controls. CONCLUSION: Our study demonstrates alterations in normal-appearing gray and white matter brain parenchyma of patients with NPSLE by means of abnormal ADC, FA, and eigenvalues. These alterations may be based on loss of tissue integrity in part due to demyelination. It is possible that DTI in the future could assist in the diagnosis of NPSLE and possibly help to further elucidate the pathogenesis of NPSLE.


Subject(s)
Diffusion Magnetic Resonance Imaging , Lupus Vasculitis, Central Nervous System/pathology , Acute Disease , Adult , Anisotropy , Case-Control Studies , Contrast Media/administration & dosage , Female , Gadolinium DTPA/administration & dosage , Humans , Male , Middle Aged
9.
Int J Radiat Oncol Biol Phys ; 62(2): 328-32, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15890571

ABSTRACT

OBJECTIVE: To determine whether changes in tumor volume occur during the course of conformal 3D radiotherapy of high-grade gliomas by use of magnetic resonance imaging (MRI) during treatment and whether these changes had an impact on tumor coverage. METHODS AND MATERIALS: Between December 2000 and January 2004, 21 patients with WHO Grades 3 to 4 supratentorial malignant gliomas treated with 3D conformal radiotherapy (median dose, 70 Gy) were enrolled in a prospective clinical study. All patients underwent T1-weighted contrast-enhancing and T2-weighted and fluid-attenuated inversion recovery (FLAIR) imaging at approximately 1 to 2 weeks before radiotherapy, during radiotherapy (Weeks 1 and 3), and at routine intervals thereafter. All MRI scans were coregistered to the treatment-planning CT. Gross tumor volume (GTV Pre-Rx) was defined from a postoperative T1-weighted contrast-enhancing MRI performed 1 to 2 weeks before start of radiotherapy. A second GTV (GTV Week 3) was defined by use of an MRI performed during Week 3 of radiotherapy. A uniform 0.5 cm expansion of the respective GTV, PTV (Pre-Rx), and PTV (Week 3) was applied to the final boost plan. Dose-volume histograms (DVH) were used to analyze any potential adverse changes in tumor coverage based on Week 3 MRI. RESULTS: All MRI scans were reviewed independently by a neuroradiologist (DGH). Two patients were noted to have multifocal disease at presentation and were excluded from analysis. In 19 cases, changes in the GTV based on MRI at Week 3 during radiotherapy were as follows: 2 cases had an objective decrease in GTV (> or =50%); 12 cases revealed a slight decrease in the rim enhancement or changes in cystic appearance of the GTV; 2 cases showed no change in GTV; and 3 cases demonstrated an increase in tumor volume. Both cases with objective decreases in GTV during treatment were Grade 3 tumors. No cases of tumor progression were noted in Grade 3 tumors during treatment. In comparison, three of 12 Grade 4 tumors had tumor progression, based on MRI obtained during Week 3 of radiotherapy. Median increase in GTV (Week 3) was 11.7 cc (range, 9.8-21.3). Retrospective DVH analysis of PTV (Pre-Rx) and PTV (Week 3) demonstrated a decrease in V(95%)(PTV volume receiving 95% of the prescribed dose) in those 3 cases. CONCLUSIONS: Routine MR imaging during radiotherapy may be essential in ensuring tumor coverage if highly conformal radiotherapy techniques such as stereotactic boost and intensity-modulated radiotherapy are used in dose-escalation trials that utilize smaller treatment margins.


Subject(s)
Brain Neoplasms/pathology , Brain Neoplasms/radiotherapy , Glioma/pathology , Glioma/radiotherapy , Adult , Aged , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Radiotherapy, Conformal , Tumor Burden
10.
MAGMA ; 17(3-6): 249-59, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15580371

ABSTRACT

The increasing development of novel targeted therapies for treating solid tumors has necessitated the development of technology to determine their efficacy in preclinical animal models. One such technology that can non-invasively quantify early changes in tumor cellularity as a result of an efficacious therapy is diffusion MRI. In this overview we present some theories as to the origin of diffusion changes as a result of tumor therapy, a robust methodology for acquisition of apparent diffusion coefficient maps and some applications of determining therapeutic efficacy in a variety therapeutic regimens and animal models.


Subject(s)
Antineoplastic Agents/therapeutic use , Diffusion Magnetic Resonance Imaging/methods , Disease Models, Animal , Drug Evaluation, Preclinical/methods , Image Interpretation, Computer-Assisted/methods , Neoplasms/diagnosis , Neoplasms/drug therapy , Animals , Neoplasms/classification , Prognosis , Treatment Outcome
11.
Eur J Cancer ; 38(16): 2147-56, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12387840

ABSTRACT

Non-invasive assessment of antineoplastic response and correlation of the location, magnitude and duration of transgene expression in vivo would be particularly useful for evaluating cancer gene therapy protocols. This review presents selected examples of how magnetic resonance (MR) has been used to assess therapeutic efficacy by non-invasive quantitation of cell kill, to detect a therapeutic response prior to a change in tumour volume and to detect spatial heterogeneity of the tumour response and quantitate transgene expression. In addition, applications of the use of bioluminescence imaging (BLI) for the evaluation of treatment efficacy and in vivo transgene expression are also presented. These examples provide an overview of areas in which imaging of animal tumour models can contribute towards improving the evaluation of experimental therapeutic agents.


Subject(s)
Magnetic Resonance Imaging/methods , Neoplasms/diagnosis , Research Design , Animals , Cell Death , Genetic Therapy/methods , Humans , Luminescent Measurements , Neoplasms/therapy , Transgenes/physiology , Treatment Outcome
12.
Invest Radiol ; 36(5): 283-91, 2001 May.
Article in English | MEDLINE | ID: mdl-11323516

ABSTRACT

RATIONALE AND OBJECTIVES: To optimize three-dimensional gadolinium magnetic resonance angiography (3D-Gd-MRA) of the aorta and runoff vessels by addressing fundamentally different requirements for temporal and spatial resolution in a single semiautomated examination. METHODS: The technique was designed to obtain pure arterial-phase 3D-Gd-MR angiograms with adequate spatial resolution for each station while avoiding incomplete enhancement due to delayed filling vessels as well as venous overlay. During gadolinium-chelate infusion, a breath-held multiphase 3D-Gd-MRA scan was initiated in the aorta by automatic triggering, followed by automatic table movement. The acquisition was tailored to the vessels of interest by tilting of the 3D volumes. A spatial resolution of 1.7 x 1.2 x 0.8 mm in the calves was achieved by use of elliptical-centric k-space reordering. Signal-to-noise ratio was maximized with a 12-element peripheral vascular coil. Twelve patients with peripheral vascular disease were studied. RESULTS: In cases of aortic occlusive disease (n = 2), dissections (n = 3), or aneurysms (n = 4), substantially delayed fill-in of reconstituted arteries, false lumens, or aneurysmal segments occurred, which was detected only on the later 3D-Gd-MRA phase. High-resolution arterial-phase scans in the calves were obtained, with only one case of substantial venous overlay. Correlation to digital subtraction angiography revealed excellent agreement of pathological findings. CONCLUSIONS: Multiphase-multistep 3D-Gd-MRA reduces the limitations of standard 3D-Gd-MRA techniques with respect to anatomic coverage, spatial resolution, and nonuniform arterial vessel enhancement.


Subject(s)
Aorta, Abdominal/diagnostic imaging , Aortic Diseases/diagnostic imaging , Contrast Media , Gadolinium DTPA , Leg/blood supply , Leg/diagnostic imaging , Magnetic Resonance Angiography/methods , Adult , Aged , Female , Humans , Male , Middle Aged , Radiography
13.
Acad Radiol ; 7(12): 1116-22, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11131056

ABSTRACT

RATIONALE AND OBJECTIVES: Electrocardiographic (ECG) gating of cardiac magnetic resonance (MR) imaging has been problematic for many reasons. The purpose of this study was to demonstrate the feasibility of using Doppler ultrasound (US) gating, either directly off the moving cardiac wall or the systolic upstroke of the arterial signal from the great vessels in neck, in alternative gating modes. MATERIALS AND METHODS: A 2.5-MHz, range-gated Doppler US device was used with A-mode guidance for gating directly off left ventricular wall motion. A 4- or 8.1-MHz, continuous-wave (CW) Doppler US device was used for gating off the systolic upstroke from the great vessels in the neck. The subject undergoing imaging held the transducer against his chest for range-gated Doppler US and against his neck for 8.1-MHz CW Doppler US. The 4-MHz transducer was strapped to the subject's neck. Modified Doppler signals were fed back into the gating circuitry of the MR imager to achieve cardiac synchrony. RESULTS: Cardiac gating was achieved by using both the range-gated technique directly off the cardiac wall and the CW method off blood flow from the great vessels. Problems occurred with radiofrequency shielding during the range-gated method; however, these problems were almost completely removed by use of the CW Doppler probes. CONCLUSION: Doppler US gating of MR images is possible and potentially could overcome many shortcomings of ECG gating. Subsequent embodiments of the technique will require improved radiofrequency shielding in the range-gated technique.


Subject(s)
Echocardiography, Doppler , Magnetic Resonance Imaging/methods , Myocardium/pathology , Feasibility Studies , Humans
14.
J Natl Cancer Inst ; 92(24): 2029-36, 2000 Dec 20.
Article in English | MEDLINE | ID: mdl-11121466

ABSTRACT

BACKGROUND: A surrogate marker for treatment response that can be observed earlier than comparison of sequential magnetic resonance imaging (MRI) scans, which depends on relatively slow changes in tumor volume, may improve survival of brain tumor patients by providing more time for secondary therapeutic interventions. Previous studies in animals with the use of diffusion MRI revealed rapid changes in tumor water diffusion values after successful therapeutic intervention. METHODS: The present study examined the sensitivity of diffusion MRI measurements in orthotopic rat brain tumors derived from implanted rat 9L glioma cells. The effectiveness of therapy for individual brain cancer patients was evaluated by measuring changes in tumor volume on neuroimaging studies conducted 6--8 weeks after the conclusion of a treatment cycle. RESULTS: Diffusion MRI could detect water diffusion changes in orthotopic 9L gliomas after doses of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU or carmustine) that resulted in as little as 0.2 log cell kill, a measure of tumor cell death. Mean apparent diffusion coefficients in tumors were found to be correlated with and highly sensitive to changes in tumor cellularity (r =.78; two-sided P =.041). The feasibility of serial diffusion MRI in the clinical management of primary brain tumor patients was also demonstrated. Increased diffusion values could be detected in human brain tumors shortly after treatment initiation. The magnitude of the diffusion changes corresponded with clinical outcome. CONCLUSIONS: These results suggest that diffusion MRI will provide an early surrogate marker for quantification of treatment response in patients with brain tumors.


Subject(s)
Biomarkers, Tumor/metabolism , Brain Neoplasms/pathology , Glioma/pathology , Magnetic Resonance Imaging , Water/metabolism , Adolescent , Adult , Animals , Antineoplastic Agents, Alkylating/administration & dosage , Brain Neoplasms/drug therapy , Brain Neoplasms/metabolism , Carmustine/administration & dosage , Diffusion , Dose-Response Relationship, Drug , Feasibility Studies , Female , Glioma/drug therapy , Glioma/metabolism , Humans , Magnetic Resonance Imaging/methods , Male , Rats , Sensitivity and Specificity , Time Factors , Treatment Outcome
15.
Radiology ; 217(2): 581-6, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11058664

ABSTRACT

At arterial phase gadolinium-enhanced magnetic resonance (MR) angiography, artifactual stenosis of the subclavian artery is sometimes seen adjacent to the subclavian vein on the side of the contrast material injection. Experiments in phantoms and in 19 patients showed increased artifact with longer echo time and higher concentration of injected contrast material. An effective method to substantially decrease this susceptibility artifact was threefold dilution of gadopentetate dimeglumine and use of a short echo time (1 msec).


Subject(s)
Artifacts , Contrast Media/administration & dosage , Gadolinium DTPA , Magnetic Resonance Angiography , Subclavian Artery/anatomy & histology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Gadolinium DTPA/administration & dosage , Humans , Infant , Male , Middle Aged , Phantoms, Imaging , Subclavian Vein/anatomy & histology
16.
Phys Med Biol ; 45(6): 1633-48, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10870715

ABSTRACT

This article presents a method for measuring three-dimensional mechanical displacement and strain fields using stimulated echo MRI. Additional gradient pulses encode internal displacements in response to an externally applied deformation. By limiting the mechanical transition to the stimulated echo mixing time, a more accurate static displacement measurement is obtained. A three-dimensional elasticity reconstruction within a region of interest having a uniform shear modulus along its boundary is performed by numerically solving discretized elasticity equilibrium equations. Data acquisition, strain measurements and reconstruction were performed using a silicone gel phantom containing an inclusion of known elastic properties. A comparison between two-dimensional and three-dimensional reconstructions from simulated and experimental displacement data shows higher accuracy from the three-dimensional reconstruction. The long-term objective of this work is to provide a method for remotely palpating and elastically quantitating manually inaccessible tissues.


Subject(s)
Magnetic Resonance Spectroscopy/methods , Echocardiography/methods , Elasticity , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Models, Statistical , Neoplasms/diagnosis , Phantoms, Imaging
17.
Gene Ther ; 7(12): 1005-10, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10871748

ABSTRACT

Detection of a therapeutic response early in the course of cancer treatment, before tumor growth delay or regression, is not currently possible in experimental models or clinical medicine. New interim measures of therapeutic response would be particularly useful in the development of cancer chemosensitization gene therapy by facilitating optimization of gene transfer protocols and prodrug dosing schedules. Diffusion MRI is a sensitive technique producing quantitative and noninvasive images of the apparent mobility of water within a tissue. We investigated the utility of diffusion MRI for detecting early changes associated with a refined cytosine deaminase (CD)/5-fluorocytosine (5FC) chemosensitization gene therapy paradigm in orthotopic 9L gliomas stably expressing the recently cloned S. cerevisiae CD gene. Mean tumor diffusion increased 31% within 8 days of initiating 5-FC treatment, preceding tumor growth arrest and regression. Complete regression of the intracranial tumor was observed in four of five treated animals, and recurrent tumor in the remaining animal exhibited water diffusion behavior similar to primary, untreated tumors. These results demonstrate the efficacy of the yCD/5FC strategy for glioma and suggest that increased tumor water diffusion is an indicator of active therapeutic intervention.


Subject(s)
Brain Neoplasms/therapy , Genetic Therapy , Glioma/therapy , Nucleoside Deaminases/genetics , Animals , Antifungal Agents/therapeutic use , Brain Neoplasms/pathology , Cytosine Deaminase , Flucytosine/therapeutic use , Glioma/pathology , Magnetic Resonance Imaging/methods , Male , Neoplasm Transplantation , Prodrugs/therapeutic use , Rats , Rats, Inbred F344 , Saccharomyces cerevisiae/enzymology , Treatment Outcome , Tumor Cells, Cultured
18.
Proc Natl Acad Sci U S A ; 97(4): 1754-9, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10677530

ABSTRACT

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent endogenous activator of the cell death pathway and functions by activating the cell surface death receptors 4 and 5 (DR4 and DR5). TRAIL is nontoxic in vivo and preferentially kills neoplastically transformed cells over normal cells by an undefined mechanism. Radiotherapy is a common treatment for breast cancer as well as many other cancers. Here we demonstrate that ionizing radiation can sensitize breast carcinoma cells to TRAIL-induced apoptosis. This synergistic effect is p53-dependent and may be the result of radiation-induced up-regulation of the TRAIL-receptor DR5. Importantly, TRAIL and ionizing radiation have a synergistic effect in the regression of established breast cancer xenografts. Changes in tumor cellularity and extracellular space were monitored in vivo by diffusion-weighted magnetic resonance imaging (diffusion MRI), a noninvasive technique to produce quantitative images of the apparent mobility of water within a tissue. Increased water mobility was observed in combined TRAIL- and radiation-treated tumors but not in tumors treated with TRAIL or radiation alone. Histological analysis confirmed the loss of cellularity and increased numbers of apoptotic cells in TRAIL- and radiation-treated tumors. Taken together, our results provide support for combining radiation with TRAIL to improve tumor eradication and suggest that efficacy of apoptosis-inducing cancer therapies may be monitored noninvasively, using diffusion MRI.


Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Membrane Glycoproteins/therapeutic use , Tumor Necrosis Factor-alpha/therapeutic use , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins , Cell Division/drug effects , Cell Division/radiation effects , DNA Fragmentation/drug effects , DNA Fragmentation/radiation effects , Female , Humans , In Situ Nick-End Labeling , Magnetic Resonance Imaging , Membrane Glycoproteins/genetics , Mice , Mice, Inbred Strains , Neoplasm Transplantation , Radiation, Ionizing , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/metabolism , Recombinant Proteins , TNF-Related Apoptosis-Inducing Ligand , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/genetics
19.
J Cogn Neurosci ; 12 Suppl 2: 130-44, 2000.
Article in English | MEDLINE | ID: mdl-11506653

ABSTRACT

Working memory is thought to include a mechanism that allows for the coding of order information. One question of interest is how order information is coded, and how that code is neurally implemented. Here we report both behavioral and fMRI findings from an experiment involved comparing two tasks, an item-memory task and an order-memory task. In each case, five letters were presented for storage, followed after a brief interval by a set of probe letters. In the case of the item-memory task, the two letters were identical, and the subject responded to the question, "Was this letter one of the items you saw?". In the case of the order-memory task, the letters were different, and subjects responded to the question, "Are these two letters in the order in which you saw them?". Behaviorally, items that were further apart in the sequence that elicited faster reaction times and higher accuracy in the Order task. Areas that were significantly more activated in the Order condition included the parietal and prefrontal cortex. Parietal activations overlapped those involved in number processing, leading to the suggestion that the underlying representation of order and numbers may share a common process, coding for magnitude.


Subject(s)
Brain Mapping/methods , Cognition/physiology , Memory/physiology , Parietal Lobe/physiology , Prefrontal Cortex/physiology , Female , Functional Laterality , Humans , Magnetic Resonance Imaging/methods , Male , Memory, Short-Term/physiology , Pattern Recognition, Visual , Reaction Time , Time Factors
20.
Med Phys ; 26(5): 707-14, 1999 May.
Article in English | MEDLINE | ID: mdl-10360530

ABSTRACT

Quantitative analysis of dynamic gadolinium-DTPA (diethylenetriamine pentaacetic acid) enhanced magnetic resonance imaging (MRI) is emerging as a highly sensitive tool for detecting malignant breast tissue. Three-dimensional rapid imaging techniques, such as keyhole MRI, yield high temporal sampling rates to accurately track contrast enhancement and washout in lesions over the course of multiple volume acquisitions. Patient motion during the dynamic acquisitions is a limiting factor that degrades the image quality, particularly of subsequent subtraction images used to identify and quantitatively evaluate regions suggestive of malignancy. Keyhole imaging is particularly sensitive to motion since datasets acquired over an extended period are combined in k-space. In this study, motion is modeled as set of translations in each of the three orthogonal dimensions. The specific objective of the study is to develop and implement an algorithm to correct the consequent phase shifts in k-space data prior to offline keyhole reconstruction three-dimensional (3D) volume breast MR acquisitions.


Subject(s)
Gadolinium , Image Processing, Computer-Assisted/methods , Mammography/methods , Algorithms , Computer Simulation , Humans , Magnetic Resonance Imaging , Models, Theoretical , Phantoms, Imaging , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...